Muhammad Safwan Bin Ahamad Bustaman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Muhammad Safwan Bin Ahamad Bustaman has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ananda Permata Fitri
HPTLC Association Indonesia Chapter, Jakarta, Indonesia
1 shared publication - Charlyna Veronika Puspitasari Pattymahu
Magister Ilmu Farmasi, Fakultas Farmasi, Universitas Airlangga
1 shared publication - Dewi Isadiartuti
Department of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
1 shared publication - Djoko Agus Purwanto
Airlangga University
1 shared publication - Idha Kusumawati
Department of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia
1 shared publication - Intan Safinar Ismail
Laboratory of Natural Products, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Malaysia
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 29 (1) , 136-148
Safety Evaluation of Spray-Dried Curcuma longa L. Extract for Pharmacopuncture: acute toxicity and neurobehavioral assessment in zebrafish
Subhan Rullyansyah, Idha Kusumawati, Intan Safinar Ismail, Djoko Agus Purwanto, Dewi Isadiartuti , Muhammad Safwan Bin Ahamad Bustaman, Muhammad Afiq Bin Ngadni, Rizky Rafi Rahmawan, Ananda Permata Fitri, Charlyna Veronika Puspitasari Pattymahu. J Pharmacopuncture 2026;29:136-48. https://doi.org/10.3831/KPI.2026.29.1.136
- 31 March 2026
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 29 (1) , 136-148
Open AccessSafety Evaluation of Spray-Dried Curcuma longa L. Extract for Pharmacopuncture: acute toxicity and neurobehavioral assessment in zebrafish
Subhan Rullyansyah, Idha Kusumawati, Intan Safinar Ismail, Djoko Agus Purwanto, Dewi Isadiartuti , Muhammad Safwan Bin Ahamad Bustaman, Muhammad Afiq Bin Ngadni, Rizky Rafi Rahmawan, Ananda Permata Fitri, Charlyna Veronika Puspitasari Pattymahu. J Pharmacopuncture 2026;29:136-48. https://doi.org/10.3831/KPI.2026.29.1.136
- 5 April 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (5) , 1159-1166
Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
BackgroundAxillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space.MethodA prospective, randomized, double-blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI).ResultsGroup A exhibited a marginally higher mean total drain output (398 +/- 205 vs. 326 +/- 198) compared to Group B, this difference did not attain statistical significance (p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/- 3.0 vs. 6 +/- 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/- 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/- 36), p = 0.222). No notable disparity in SSI rates between the groups was identified.ConclusionIn conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow-up periods for a more comprehensive understanding.
- 5 April 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (5) , 1159-1166
Haemoblock hemostatic substance in reducing seroma formation post axillary lymph node dissection following breast conserving surgery
BackgroundAxillary lymph node dissection (ALND) in breast cancer management, necessitates a nuanced understanding of complications that may impede treatment progression. This study scrutinize the impact of Haemoblock hemostatic solution, evaluation it's potential in reducing seroma complication by controlling lymph flow and obliterating axillary dead space.MethodA prospective, randomized, double-blinded controlled trial was conducted with 58 patients undergoing breast conserving surgery (BCS) and ALND, stratified into two groups: Group A (ALND + Haemoblock, n = 29) and Group B (ALND + placebo, n = 29). Postoperative drainage charts were monitored, with the primary endpoint being the time to drain removal, Additionally, patients were observed for surgical site infection (SSI).ResultsGroup A exhibited a marginally higher mean total drain output (398 +/- 205 vs. 326 +/- 198) compared to Group B, this difference did not attain statistical significance (p = 0.176). Equally, the mean time to drain removal demonstrated no discernible distinction between the two groups (6 +/- 3.0 vs. 6 +/- 3.0, Group A vs. Group B, p = 0.526). During follow up, nine patients in Group A required seroma aspiration (mean aspiration 31 +/- 73) as compared to Group B, 6 patients required aspiration (mean aspiration 12 +/- 36), p = 0.222). No notable disparity in SSI rates between the groups was identified.ConclusionIn conclusion, the administration of Haemoblock did not manifest a discernible effect in mitigating seroma production, hastening drain removal, or influencing SSI rates following ALND. The study underscores the intricate and multifactorial nature of seroma formation, suggesting avenues for future research to explore combined interventions and protracted follow-up periods for a more comprehensive understanding.